|
PT2099826E
(pt)
*
|
2007-01-05 |
2014-01-09 |
Univ Zuerich |
Anticorpo anti-beta-amilóide e suas utilizações
|
|
HRP20140049T1
(hr)
|
2007-01-05 |
2014-02-28 |
University Of Zürich |
Anti beta-amiloid antitijela i njihova upotreba
|
|
EP2210901A4
(en)
*
|
2007-10-19 |
2012-04-25 |
Immunas Pharma Inc |
FOR THE SPECIFIC BINDING TO AN OLIGOMICALLY ABLE ANTIBODY AND ITS USE
|
|
EP2246427B1
(en)
|
2008-02-08 |
2016-11-30 |
Immunas Pharma, Inc. |
Antibodies capable of binding specifically to amyloid beta-oligomers, and use thereof
|
|
CA2730073A1
(en)
*
|
2008-07-09 |
2010-01-14 |
University Of Zurich |
Method of promoting neurogenesis
|
|
WO2010069603A1
(en)
|
2008-12-19 |
2010-06-24 |
Neurimmune Therapeutics Ag |
Human anti-alpha-synuclein autoantibodies
|
|
WO2010119704A1
(en)
|
2009-04-17 |
2010-10-21 |
Immunas Pharma, Inc. |
Antibodies that specifically bind to a beta oligomers and use thereof
|
|
DK2462162T3
(en)
|
2009-08-06 |
2017-01-16 |
Immunas Pharma Inc |
Antibodies that specifically bind to A-beta oligomers and their use
|
|
AR080301A1
(es)
|
2010-02-24 |
2012-03-28 |
Immunogen Inc |
Anticuerpos e inmunoconjugados del receptor 1 de folato y sus usos
|
|
WO2012096960A2
(en)
|
2011-01-10 |
2012-07-19 |
The Regents Of The University Of Michigan |
Stem cell factor inhibitor
|
|
US20150018408A1
(en)
*
|
2013-07-10 |
2015-01-15 |
The Regents Of The University Of Michigan |
Therapeutic antibodies and uses thereof
|
|
CA2858350A1
(en)
|
2011-01-14 |
2013-07-19 |
The Regents Of The University Of California |
Therapeutic antibodies against ror-1 protein and methods for use of same
|
|
PL2694106T3
(pl)
*
|
2011-04-01 |
2018-06-29 |
Immunogen, Inc. |
Sposoby zwiększania skuteczności terapii przeciwnowotworowej opartej na receptorze folr1
|
|
CN103796679B
(zh)
|
2011-06-23 |
2016-10-19 |
比奥根国际神经科学公司 |
抗-α突触核蛋白结合分子
|
|
GB201110938D0
(en)
*
|
2011-06-27 |
2011-08-10 |
Iti Scotland Ltd |
Compounds
|
|
EP2756002A4
(en)
*
|
2011-09-16 |
2015-04-08 |
Univ Texas |
COMPOSITIONS AND METHODS RELATED TO THE REPAIR OF DNA DAMAGES
|
|
KR20150046316A
(ko)
*
|
2012-08-31 |
2015-04-29 |
이뮤노젠 아이엔씨 |
엽산 수용체 1의 검출을 위한 진단성 검정 및 키트
|
|
JP2016509582A
(ja)
|
2012-12-19 |
2016-03-31 |
アンプリミューン， インコーポレイテッド |
抗ヒトｂ７−ｈ４抗体およびその使用
|
|
US9534044B2
(en)
*
|
2013-02-28 |
2017-01-03 |
United Arab Emirates University |
Alpha-synuclein antibodies and uses thereof
|
|
CN114621346B
(zh)
*
|
2013-08-21 |
2025-06-10 |
德克萨斯州大学系统董事会 |
用于靶向连接蛋白半通道的组合物和方法
|
|
PT3038650T
(pt)
|
2013-08-30 |
2021-08-25 |
Immunogen Inc |
Anticorpos e ensaios para a deteção do recetor de folato 1
|
|
US20160264684A1
(en)
*
|
2013-10-10 |
2016-09-15 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
CA2924520C
(en)
|
2013-11-01 |
2023-09-26 |
Ibc Pharmaceuticals, Inc. |
Bispecific antibodies that neutralize both tnf-alpha and il-6: novel therapeutic agent for autoimmune disease
|
|
US20160356794A1
(en)
*
|
2014-02-10 |
2016-12-08 |
Merck Sharp & Dohme Corp. |
Antibodies that bind to human tau and assay for quantifying human tau using the antibodies
|
|
EP3119805A1
(en)
|
2014-03-20 |
2017-01-25 |
Wellstat Diagnostics, LLC |
Antibodies and methods for the detection of cell death
|
|
CA3104268A1
(en)
|
2014-04-10 |
2015-10-15 |
Obi Pharma Inc. |
Antibodies, pharmaceutical compositions and uses thereof
|
|
CR20170060A
(es)
|
2014-08-19 |
2017-04-18 |
Merck Sharp & Dohme |
Anticuerpos anti tigit
|
|
CR20170067A
(es)
|
2014-09-16 |
2017-05-10 |
Ovascience Inc |
Anticuerpos anti-vasa y metodos de producción y uso de los mismos
|
|
US9732148B2
(en)
*
|
2014-10-16 |
2017-08-15 |
Genentech, Inc. |
Anti-α-synuclein antibodies and methods of use
|
|
US20170306046A1
(en)
|
2014-11-12 |
2017-10-26 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
US9879087B2
(en)
|
2014-11-12 |
2018-01-30 |
Siamab Therapeutics, Inc. |
Glycan-interacting compounds and methods of use
|
|
MA41115A
(fr)
|
2014-12-02 |
2017-10-10 |
Biogen Int Neuroscience Gmbh |
Procédé de traitement de la maladie d'alzheimer
|
|
EP3233897B1
(en)
*
|
2014-12-19 |
2021-02-17 |
Universite de Nantes |
Anti il-34 antibodies
|
|
WO2016120843A1
(en)
*
|
2015-01-29 |
2016-08-04 |
Technophage, Investigação E Desenvolvimento Em Biotecnologia, Sa |
Antibody molecules and peptide delivery systems for use in alzheimer's disease and related disorders
|
|
EP3262070A4
(en)
|
2015-02-24 |
2018-07-25 |
Rpeptide, LLC |
Anti-amyloid-beta antibodies
|
|
US10517948B2
(en)
|
2015-03-11 |
2019-12-31 |
The Board Of Regents Of The University Of Texas System |
Anti-DC-HIL antibodies for cancer diagnosis, prognosis and therapy
|
|
WO2016149116A1
(en)
*
|
2015-03-13 |
2016-09-22 |
University Of Maryland, Baltimore |
Antibodies targeting s100b and methods of use
|
|
CN107530427A
(zh)
*
|
2015-03-27 |
2018-01-02 |
南加利福尼亚大学 |
针对用于实体肿瘤的治疗的lhr的car t细胞疗法
|
|
CA2988912C
(en)
*
|
2015-06-10 |
2023-09-12 |
National Research Council Of Canada |
Carbonic anhydrase ix-specific antibodies and uses thereof
|
|
WO2016205566A1
(en)
*
|
2015-06-16 |
2016-12-22 |
The Regents Of The University Of California |
Fzd7 specific antibodies and vaccines to treat cancer and control stem cell function
|
|
JP6976241B2
(ja)
*
|
2015-08-14 |
2021-12-08 |
メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. |
抗ｔｉｇｉｔ抗体
|
|
MX2018002610A
(es)
|
2015-09-02 |
2018-09-27 |
Immutep Sas |
Anticuerpos anti-lag-3.
|
|
JP6880006B2
(ja)
|
2015-09-17 |
2021-06-02 |
イミュノジェン， インコーポレイテッド |
抗ｆｏｌｒ１免疫複合体を含む治療組み合わせ
|
|
AU2016354688B2
(en)
|
2015-11-09 |
2021-12-16 |
The University Of British Columbia |
Epitopes in Amyloid beta mid-region and conformationally-selective antibodies thereto
|
|
EP3374379A4
(en)
|
2015-11-09 |
2019-05-15 |
The University Of British Columbia |
N-TERMINAL EPITOPES IN AMYLOID BETA AND CONFORMATION-SELECTIVE ANTIBODIES
|
|
JP7452829B2
(ja)
|
2015-11-09 |
2024-03-19 |
ザ・ユニバーシティ・オブ・ブリティッシュ・コロンビア |
アミロイドベータのエピトープおよびそれに対する抗体
|
|
CN108463248B
(zh)
|
2015-11-12 |
2022-10-21 |
西雅图基因公司 |
聚糖相互作用化合物及使用方法
|
|
CN116514976A
(zh)
|
2016-03-04 |
2023-08-01 |
Jn生物科学有限责任公司 |
针对tigit的抗体
|
|
WO2017160587A1
(en)
*
|
2016-03-16 |
2017-09-21 |
Abeome Corporation |
Neutralizing monoclonal antibodies to il-25 and uses thereof
|
|
US20180362660A1
(en)
*
|
2016-05-09 |
2018-12-20 |
Schickwann Tsai |
Anti-penumbra monoclonal antibodies for detection and therapy of normal and abnormal B lymphocytes
|
|
WO2017218691A1
(en)
*
|
2016-06-16 |
2017-12-21 |
The Board Of Trustees Of The Leland Stanford Junior University |
Humanized and chimeric monoclonal antibodies to cd81
|
|
KR102550991B1
(ko)
*
|
2016-07-18 |
2023-07-04 |
더 유니버시티 오브 브리티쉬 콜롬비아 |
아밀로이드 베타에 대한 항체
|
|
JOP20170154B1
(ar)
*
|
2016-08-01 |
2023-03-28 |
Omeros Corp |
تركيبات وطرق لتثبيط masp-3 لعلاج أمراض واضطرابات مختلفة
|
|
TW201827467A
(zh)
*
|
2016-11-03 |
2018-08-01 |
比利時商健生藥品公司 |
焦穀胺酸類澱粉蛋白－β之抗體及其用途
|
|
US20180125920A1
(en)
|
2016-11-09 |
2018-05-10 |
The University Of British Columbia |
Methods for preventing and treating A-beta oligomer-associated and/or -induced diseases and conditions
|
|
EP3541847A4
(en)
|
2016-11-17 |
2020-07-08 |
Seattle Genetics, Inc. |
COMPOUNDS INTERACTING WITH GLYCANE AND METHODS OF USE
|
|
EP3544628A4
(en)
|
2016-11-23 |
2020-11-18 |
Immunoah Therapeutics, Inc. |
4-1BB BINDING PROTEINS AND THEIR USES
|
|
CN106749657A
(zh)
*
|
2016-12-13 |
2017-05-31 |
中国农业科学院哈尔滨兽医研究所 |
一种抗体信号肽及其应用
|
|
US11458169B2
(en)
|
2017-02-22 |
2022-10-04 |
H. Lee Moffitt Cancer Center And Research Institute, Inc. |
TIM3-binding chimeric antigen receptors
|
|
EP3589654A1
(en)
*
|
2017-03-02 |
2020-01-08 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Antibodies having specificity to nectin-4 and uses thereof
|
|
EP3589319A4
(en)
|
2017-03-03 |
2021-07-14 |
Seagen Inc. |
GLYCAN INTERACTING COMPOUNDS AND METHOD OF USE
|
|
EP3608335A4
(en)
*
|
2017-04-05 |
2020-04-29 |
XDCExplorer (Shanghai) Co., Ltd. |
HUMANIZED ANTI-TPBG ANTIBODY, PRODUCTION METHOD THEREFOR, CONJUGATE THEREOF AND APPLICATIONS
|
|
JP7280238B2
(ja)
*
|
2017-07-17 |
2023-05-23 |
ヤンセン バイオテツク，インコーポレーテツド |
フィブロネクチンｉｉｉ型ドメインに対する抗原結合領域及びその使用方法
|
|
US12286469B2
(en)
|
2017-07-18 |
2025-04-29 |
The University Of British Columbia |
Humanized antibodies binding to amyloid-beta (A-beta)
|
|
EP3658172A4
(en)
|
2017-07-25 |
2021-05-05 |
TrueBinding, Inc. |
TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND HIS LIGAND
|
|
AU2018321335B2
(en)
|
2017-08-22 |
2025-08-14 |
Biogen Ma Inc. |
Pharmaceutical compositions containing anti-beta amyloid antibodies
|
|
TW202003576A
(zh)
*
|
2018-05-10 |
2020-01-16 |
美商艾博視訊有限公司 |
活化cd40之單株抗體及其用途
|
|
CA3100896C
(en)
*
|
2018-05-30 |
2023-08-29 |
National Health Research Institutes |
Anti-abeta antibodies and uses thereof
|
|
DK3806903T5
(da)
*
|
2018-06-14 |
2024-08-19 |
2Seventy Bio Inc |
Cd79a kimæriske antigenreceptorer
|
|
JP7623939B2
(ja)
*
|
2018-07-09 |
2025-01-29 |
マルチチュード インコーポレーテッド |
葉酸受容体アルファに特異的な抗体
|
|
EA202190647A1
(ru)
*
|
2018-09-17 |
2021-09-09 |
Абкуро, Инк. |
Антитела к klrg1
|
|
KR20210121136A
(ko)
*
|
2019-01-29 |
2021-10-07 |
상하이 지아오통 유니버시티 |
키메라 항원 수용체 및 그 용용
|
|
CN113711036B
(zh)
|
2019-01-30 |
2025-03-18 |
真和制药有限公司 |
抗gal3抗体及其用途
|
|
WO2020180706A1
(en)
*
|
2019-03-02 |
2020-09-10 |
The Board Of Trustees Of The Leland Stanford Junior University |
Therapeutic antigen binding proteins specific for cd93 and methods of use thereof
|
|
MA55491A
(fr)
|
2019-03-26 |
2022-02-09 |
Janssen Pharmaceutica Nv |
Anticorps anti-pyroglutamate-amyloïde bêta et leurs utilisations
|
|
CN110343180B
(zh)
*
|
2019-07-25 |
2021-03-30 |
北京免疫方舟医药科技有限公司 |
抗ctla-4抗体及其应用
|
|
WO2021055670A1
(en)
|
2019-09-20 |
2021-03-25 |
Avx Corporation |
Somatic cell-based electrical biosensor
|
|
WO2021138380A2
(en)
*
|
2019-12-30 |
2021-07-08 |
University Of Louisville Research Foundation, Inc. |
Virus-like particle binding agents, related compositions, and related methods
|
|
CN111793136A
(zh)
*
|
2020-05-11 |
2020-10-20 |
廊坊天光生物技术有限公司 |
一种nmp22抗体对及其应用
|
|
CN111808191A
(zh)
*
|
2020-05-11 |
2020-10-23 |
廊坊天光生物技术有限公司 |
一种用于检测血清中vegf含量的抗体对及其用途
|
|
WO2021231982A1
(en)
*
|
2020-05-14 |
2021-11-18 |
City Of Hope |
Smc1a antibodies and uses thereof
|
|
CN116157151A
(zh)
|
2020-05-26 |
2023-05-23 |
真和制药有限公司 |
通过阻断半乳凝素-3治疗炎性疾病的方法
|
|
US11820824B2
(en)
|
2020-06-02 |
2023-11-21 |
Arcus Biosciences, Inc. |
Antibodies to TIGIT
|
|
EP4171633A1
(en)
|
2020-06-25 |
2023-05-03 |
Merck Sharp & Dohme LLC |
High affinity antibodies targeting tau phosphorylated at serine 413
|
|
WO2022020680A1
(en)
|
2020-07-23 |
2022-01-27 |
Othair Prothena Limited |
Anti-abeta antibodies
|
|
US20230357391A1
(en)
*
|
2020-08-04 |
2023-11-09 |
Exelixis, Inc. |
Cd47 binding agents and uses thereof
|
|
BR112023002843A2
(pt)
|
2020-08-18 |
2023-03-14 |
Omeros Corp |
Anticorpo isolado ou fragmento de ligação a antígeno do mesmo, molécula de ácido nucleico, vetor de clonagem ou cassete de expressão, célula, métodos para gerar um anticorpo isolado ou fragmento de ligação a antígeno do mesmo, para determinar a presença ou quantidade de fator d maduro e de pró-fator d em uma amostra de teste, para avaliar o grau de ativação do caminho alternativo de complemento (apc) em uma amostra de teste, para monitorar a eficácia de tratamento com um anticorpo inibidor de lectina serina protease 3 de ligação a manana ou fragmento de ligação a antígeno do mesmo e para tratar um sujeito mamífero sofrendo de ou em risco de desenvolver uma doença ou distúrbio do caminho alternativo, composição, substrato para o uso em um imunoensaio, kit para detectar a presença ou quantidade de fator d maduro em uma amostra de teste, composição farmacêutica, e, artigo de fabricação
|
|
CN112778419A
(zh)
*
|
2021-02-01 |
2021-05-11 |
重庆中元汇吉生物技术有限公司 |
抗ck-mb的抗体或其抗原结合部分及其应用
|
|
US20240117047A1
(en)
*
|
2021-02-11 |
2024-04-11 |
The Regents Of The University Of California |
Monoclonal antibodies specific for human ror1
|
|
CN113075398A
(zh)
*
|
2021-03-23 |
2021-07-06 |
中国医学科学院输血研究所 |
一种血浆中特异性IgG抗体的定量测定方法
|
|
WO2023076926A1
(en)
*
|
2021-10-26 |
2023-05-04 |
Bach Diagnostics Inc. |
Lateral flow assay for the diagnosis of dermatmycoses
|
|
JP2025537193A
(ja)
*
|
2022-11-08 |
2025-11-14 |
フェインズ セラピューティクス，インコーポレーテッド |
抗５ｔ４抗体及びその使用
|
|
US12534540B2
(en)
*
|
2023-01-23 |
2026-01-27 |
Clemson University Research Foundation |
CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa
|
|
US20240352102A1
(en)
*
|
2023-01-27 |
2024-10-24 |
The United States Government As Represented By The Department Of Veterans Affairs |
Compositions for treating tauopathies and methods of use thereof
|
|
CN121464157A
(zh)
*
|
2023-02-28 |
2026-02-03 |
梅约医学教育与研究基金会 |
结合至b细胞活化因子受体多肽的分子
|
|
CN119306826B
(zh)
*
|
2023-07-11 |
2025-06-20 |
东莞市朋志生物科技有限公司 |
抗白介素-6抗体、检测白介素-6的试剂和试剂盒
|
|
WO2025044931A1
(zh)
*
|
2023-08-25 |
2025-03-06 |
康诺亚生物医药科技（成都）有限公司 |
阿尔茨海默病治疗剂的开发和应用
|
|
WO2026060081A1
(en)
*
|
2024-09-12 |
2026-03-19 |
Denali Therapeutics Inc. |
Anti-amyloid beta antibodies and methods of use
|
|
CN119613538B
(zh)
*
|
2024-12-12 |
2025-10-17 |
浙江大学医学院附属第一医院(浙江省第一医院) |
抗h10亚型流感病毒血凝素蛋白中和性单克隆抗体1e10及其应用
|
|
CN120209138B
(zh)
*
|
2025-05-29 |
2025-10-03 |
杭州广科安德生物科技有限公司 |
Tff3、osm蛋白的抗体及其组合和在结直肠癌诊断中的应用
|
|
CN121319156A
(zh)
*
|
2025-11-19 |
2026-01-13 |
北京中科蓝玉生物科技有限公司 |
抗猪繁殖与呼吸综合征病毒gp3蛋白的抗体及其应用
|